Correlation Between Mesa Laboratories and Lexeo Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Mesa Laboratories and Lexeo Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mesa Laboratories and Lexeo Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mesa Laboratories and Lexeo Therapeutics, Common, you can compare the effects of market volatilities on Mesa Laboratories and Lexeo Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mesa Laboratories with a short position of Lexeo Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mesa Laboratories and Lexeo Therapeutics,.
Diversification Opportunities for Mesa Laboratories and Lexeo Therapeutics,
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mesa and Lexeo is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Mesa Laboratories and Lexeo Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lexeo Therapeutics, and Mesa Laboratories is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mesa Laboratories are associated (or correlated) with Lexeo Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lexeo Therapeutics, has no effect on the direction of Mesa Laboratories i.e., Mesa Laboratories and Lexeo Therapeutics, go up and down completely randomly.
Pair Corralation between Mesa Laboratories and Lexeo Therapeutics,
Given the investment horizon of 90 days Mesa Laboratories is expected to generate 0.57 times more return on investment than Lexeo Therapeutics,. However, Mesa Laboratories is 1.76 times less risky than Lexeo Therapeutics,. It trades about 0.0 of its potential returns per unit of risk. Lexeo Therapeutics, Common is currently generating about -0.01 per unit of risk. If you would invest 17,234 in Mesa Laboratories on November 9, 2024 and sell it today you would lose (3,061) from holding Mesa Laboratories or give up 17.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 64.1% |
Values | Daily Returns |
Mesa Laboratories vs. Lexeo Therapeutics, Common
Performance |
Timeline |
Mesa Laboratories |
Lexeo Therapeutics, |
Mesa Laboratories and Lexeo Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mesa Laboratories and Lexeo Therapeutics,
The main advantage of trading using opposite Mesa Laboratories and Lexeo Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mesa Laboratories position performs unexpectedly, Lexeo Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lexeo Therapeutics, will offset losses from the drop in Lexeo Therapeutics,'s long position.Mesa Laboratories vs. Novanta | Mesa Laboratories vs. Itron Inc | Mesa Laboratories vs. Fortive Corp | Mesa Laboratories vs. Vishay Precision Group |
Lexeo Therapeutics, vs. Constellation Brands Class | Lexeo Therapeutics, vs. Naked Wines plc | Lexeo Therapeutics, vs. Sea | Lexeo Therapeutics, vs. Weibo Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |